Literature DB >> 22976058

The genetics of multiple sclerosis.

Rui Lin1, Jac Charlesworth, Ingrid van der Mei, Bruce V Taylor.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Improved prevention and treatment will depend on a greater understanding of the causes and mechanisms involved in its onset and progression. MS is clearly driven by both environmental and genetic factors. Established contributory environmental factors include lower ultraviolet radiation exposure and lower vitamin D levels, Epstein-Barr virus and smoking. Our current understanding of MS genetics is undergoing a major upgrade as new genetic technologies are applied to large MS studies. In this article, we review the current literature describing a genetic contribution to MS susceptibility and review the methods to detect genetic variants that may underlie the genetic contribution to MS. We also consider how reporting of genetic discoveries in MS in the lay press has caused some confusion among patients and their families, who, not surprisingly, think that these discoveries can be translated into an available genetic test to diagnose MS or recognise family members at risk of developing MS. We review the current limited clinical use of genetics in the diagnosis and management of MS.

Entities:  

Mesh:

Year:  2012        PMID: 22976058     DOI: 10.1136/practneurol-2012-000276

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  7 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Genotype and Phenotype in Multiple Sclerosis-Potential for Disease Course Prediction?

Authors:  Vilija G Jokubaitis; Yuan Zhou; Helmut Butzkueven; Bruce V Taylor
Journal:  Curr Treat Options Neurol       Date:  2018-04-24       Impact factor: 3.598

3.  Stressed cybrids model demyelinated axons in multiple sclerosis.

Authors:  Laura Llobet; Aurora Gómez-Durán; Ruth Iceta; Eldris Iglesias; Julio Montoya; Jesús Martín-Martínez; José Ramón Ara; Eduardo Ruiz-Pesini
Journal:  Metab Brain Dis       Date:  2013-04-24       Impact factor: 3.584

4.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 5.  A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.

Authors:  V V Bashinskaya; O G Kulakova; A N Boyko; A V Favorov; O O Favorova
Journal:  Hum Genet       Date:  2015-09-25       Impact factor: 4.132

6.  Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.

Authors:  Yohannes Haile; Maryam Nakhaei-Nejad; Paul A Boakye; Glen Baker; Peter A Smith; Allan G Murray; Fabrizio Giuliani; Nadia Jahroudi
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 7.  Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances.

Authors:  Zhicheng Liu; Jeffrey Waters; Bin Rui
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.